(MENAFN- GlobeNewsWire - Nasdaq) Portland, OR, May 26, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled,“ cell analysis market by Product (Consumable, Services, Instrument, and Software), by Technique (Flow Cytometry, Mass Spectrometry, Next Generation Sequencing, Polymerase Chain Reaction and Others), by Application (Oncology, Immunology, Cardiology, Genetic Disease, Stem Cells and Others), by End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Laboratories and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 ”. According to the report, the global cell analysis industry generated $17.1 billion in 2022 and is estimated to reach $42.9 billion by 2032, exhibiting a CAGR of 9.5% from 2023 to 2032. Download Sample Report-
Prime determinants of growth
An increase in the prevalence of chronic disease, advancement in cell analysis technology, and a surge in the popularity of personalized medicine approaches drive the growth of the global Cell Analysis market. However, the high cost of single-cell analysis and the dearth of skilled professionals are hampering the cell analysis market growth. On the contrary, the growing prevalence of chronic and genetic diseases and the high growth potential of single-cell sequencing are expected to offer remunerative opportunities for the expansion of the cell analysis market during the forecast period.
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2023–2032 |
| Base Year | 2022 |
| Market Size in 2022 | $17.1 billion |
| Market Size in 2032 | $42.9 billion |
| CAGR | 9.5% |
No. of Pages in Report
| 264
|
Segments Covered
| Product, Technique, Application, End User, and Region.
|
| Drivers | Increase in the prevalence of chronic disease
Advancements in cell analysis technology
Surge in the popularity of personalized medicine approach
|
Opportunities
| High growth potential of single-cell sequencing
|
Restraints
| High cost of single-cell analysis
|
Covid-19 Scenario
The global cell analysis market was positively impacted during the pandemic, owing to a surge in demand for cell analysis as researchers utilized cell analysis techniques to gain further insights into the virus and develop potential treatments. Moreover, an increase in government funding during the pandemic for research and development of COVID-19-related therapies led to an increase in the usage of cell analytics across the world. This, in turn, resulted to a surge in demand for cell analysis tools such as flow cytometers, microscopes, and cell counters that provides various growth opportunities for companies operating in the cell analysis market.
Procure Complete Report (249 Pages PDF with Insights, Charts, Tables, and Figures)
The consumable segment to maintain its leadership status throughout the forecast period
Based on product, the consumable segment held the highest market share in 2022, accounting for nearly one-third of the global cell analysis market revenue, and is estimated to maintain its leadership status throughout the forecast period, owing to a rise in the adoption of advanced and innovative consumables such as multi-omics assays among research and academic institutes that boost the growth of the market. However, the services segment is projected to grow fastest with a CAGR of 10.4% from 2023 to 2032, owing to increased demand for outsourcing and personalized medicine.
The flow cytometry segment to maintain its leadership status throughout the forecast period
Based on technique, the flow cytometry segment held the highest market share in 2022, accounting for more than one-third of the global cell analysis market revenue, and is estimated to maintain its leadership status throughout the forecast period, owing to an increase in genome mapping programs, rise in applications of flow cytometry, increase in healthcare expenditure and technological advancements in sequencing platforms. The same segment is estimated to showcase the fastest CAGR of 10.2% throughout the forecast period.
The oncology segment to maintain its leadership status throughout the forecast period
Based on application, the oncology segment held the highest market share in 2022, accounting for more than one-fourth of the global cell analysis market revenue, and is estimated to maintain its leadership status throughout the forecast period, owing to the rise in the prevalence of cancer across the globe. The same segment would portray the fastest CAGR of 10.5% from 2023 to 2032.
For Purchase Inquiry-
The biotechnology and pharmaceutical company segment to maintain its lead position during the forecast period
Based on end users, the biotechnology and pharmaceutical companies segment accounted for the largest share in 2022, contributing to nearly two-fifths of the global cell analysis market revenue, owing to technological advancement such as the use of microfluidics for the development of next-generation therapies have increased the adoption of cell analysis by biotechnology and pharmaceutical companies. The same segment is estimated to showcase the fastest CAGR of 10.5% from 2023 to 2032.
North America to maintain its dominance by 2032
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global cell analysis market revenue and is expected to retain its dominance in terms of revenue throughout the forecast period. The cell analysis market is mainly driven by well-established healthcare systems, an increase in the number of geriatric patients, and supportive reimbursement policies in the healthcare system and an increasing number of healthcare facilities offering proton therapy in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 10.5% from 2023 to 2032 owing to improving healthcare infrastructure in the region and large patient populations for target diseases. In addition, the expanding presence of key market players in the region propels market growth.
Leading Market Players: -
Becton, Dickinson, and Company Danaher Corporation QIAGEN N.V. Thermo Fisher Scientific, Inc. Illumina Inc. Bio-Rad Laboratories Agilent Technologies Inc. Sartorius AG Biomerieux SA Standard BioTools Inc.
The report provides a detailed analysis of these key players in the global cell analysis market. These players have adopted strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Similar Research Reports for Information, Communication and Technology:
dialysis market- global opportunity analysis and industry forecast, 2021–2030
medical electrodes market- global opportunity analysis and industry forecast, 2021–2030
tattoo removal market- global opportunity analysis and industry forecast, 2021–2030
neurovascular devices market- global opportunity analysis and industry forecast, 2021–2030
elderly and disabled assistive devices market- global opportunity analysis and industry forecast, 2021–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link:
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including life sciences , Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web:
Tags cell analysis cell analysis technology Related Links
oncolytic virus immunotherapy market ambulatory polysomnography (psg) systems market brain implant market enzymes for bioenergy application market surgical dressing market gastric cancer market brazil medical aesthetic devices market mitral valve disease market dental tourism market
MENAFN26052023004107003653ID1106323722
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.